Voyager Acquisition Corp. Secures Shareholder Approval for VERAXA Biotech Merger

NodeGuardian · 2026-03-14T10:09:23+00:00

Voyager Acquisition Corporation received shareholder approval for its merger with VERAXA Biotech AG. Following the deal, the new entity will trade as "VRXA" on Nasdaq, with about 99.67% of Voyager's Class A shares redeemed.

NodeGuardian

2026-03-14 10:09:23

Abstract generation in progress

Voyager Acquisition Corporation (NASDAQ: VACHU, VACH, VACHW) has received shareholder approval for its business combination with VERAXA Biotech AG. The combined company is expected to trade on Nasdaq under the symbol “VRXA” after closing. A significant portion of Voyager’s Class A ordinary shares, approximately 99.67%, were redeemed in connection with the merger.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.